PARAG A. MAJMUDAR, MD
1585 N. Barrington Road, Suite 502, Hoffman Estates, IL 60194 Tel: (847) 882-5900 FAX: (847) 882-6028
SCIENTIFIC AND SCHOLARLY ACTIVITIES:
PUBLICATIONS IN PEER-REVIEWED JOURNALS:
1. Goins KM, Khadem J, Dana MR, Majmudar PA, Ernest JT: Photodynamic Biologic Tissue Glue to Enhance Corneal Wound Healing After Radial Keratotomy, J Cataract Refract Surg, November 1997, 23:1331-1338.
2. Majmudar PA, Brenart R, Epstein RJ, Topical Mitomycin-C For Massive Subepithelial Fibrosis Following Radial Keratotomy. Cornea 1998, 17(2): 242-243.
3. Majmudar PA, Epstein RJ, Antimetabolites in Ocular Surface Neoplasia. Current Opinion in Ophthalmology, August 1998, 9(4), 35-39.
4. Goins KM, Khadem J, Majmudar PA: Relative Strength of Photodynamic Biologic Tissue Glue in Penetrating Keratoplasty in Cadaver Eyes, J Cataract Refract Surg, December 1998, 24:1566-1570.
4. Majmudar PA, Forstot SL, Nirankari VS, Dennis RF, Brenart R, Epstein RJ: Topical Mitomycin-C for Subepithelial Fibrosis after Refractive Corneal Surgery. Ophthalmol 2000; 107:89-94.
5. Rao SN, Majmudar, PA. LASIK after PRK, Discussion, Ophthalmol 2001; 108,1479. 6. Rao SN, Raviv T, Majmudar PA, Epstein RJ. Role of Orbscan II in Screening Keratoconus
Patients before Refractive Surgery, Ophthalmol 2002; 109:1642-1646.
7. Lane HA, Swale J, Majmudar PA. Prophylactic Use of Mitomycin-C in the Management of Buttonholed LASIK Flaps. J Cataract Refract Surg 2003 February, 29:390-392.
8. Majmudar PA et al. Non-Invasive Diagnosis of Epithelial Downgrowth following Penetrating Keratoplasty. In Review for Cornea
9. Muller LT, Candal EM, Epstein RJ, Dennis RF, Majmudar PA. Transepithelial
phototherapeutic keratectomy/photorefractive keratectomy (PTK/PRK) with Adjunctive Mitomycin-C for Complicated LASIK Flaps, Journal of Cataract and Refractive Surgery, December 2004.
10. Majmudar PA, “The Role of Mitomycin-C in Corneal Refractive Surgery,” Techniques in Ophthalmology. Vol. 2, No. 2, June 2004, 43-9.
2. Book Chapter: Majmudar PA. “Interstitial Keratitis,” Ophthalmology Online Textbook,
www.emedicine.com, 1999.
3. Book Chapter: Majmudar PA. “Laser Thermal Keratoplasty for Hyperopia,” Ophthalmology Online Textbook, www.emedicine.com, 1999.
4. Muller LT, Majmudar PA. “Surgical Treatment of Post-RK Hyperopia.” In: Sher N, ed. Surgery for Hyperopia. Thorofare, NJ: Slack, Inc,; 2004: p.
5. Candal EM, Majmudar PA. “Surface Ablation with Prophylactic MMC for High Myopia and High-Risk Patients.” In: Probst L, ed. LASIK: Advances, Controversies and Custom. Thorofare, NJ: Slack Inc.; 2004: p.
6. Majmudar PA, Book Chapter, In: Feder RS, Cirino AC, Rapuano CJ, ed. Refractive Surgery Handbook – Surgical Guides and Practice Cases, Lippincott, Williams & Wilkins, in progress
AUDIO-VISUAL EDUCATIONAL MATERIALS:
1. Majmudar, PA: LASIK: Advanced Techniques and Complex Cases. “The Role of Mitomycin-C in Mitomycin-Complicated LASIK.” Boston: Ophthalmology Interactive; 2000. (Mitomycin-CD-ROM)
2. Majmudar, PA: VisionQuest 2000: Systematic LASIK. “LASIK Pearls.” Boston: Physician Ed; 2001. (CD-ROM)
3. Majmudar, PA: VisionQuest 2000: Systematic LASIK. “Avoiding LASIK Complications.” Boston: Physician Ed; 2001. (CD-ROM)
4. Majmudar, PA: VisionQuest 2001: Systematic LASIK. “Avoiding and Recognizing Complications.” Boston: Physician Education, Inc.; 2001. (CD-ROM)
5. Majmudar, PA: VisionQuest 2000: Systematic LASIK. “Patient Selection: Good and Bad Candidates.” Boston: Physician Ed; 2001. (CD-ROM)
6. Majmudar PA, Epstein RJ. “Mitomycin-C Treatment for Post-PRK Corneal Haze.” Video Journal of Cataract and Refractive Surgery. 2001.
PUBLICATIONS IN NON-PEER-REVIEWED JOURNALS:
1. Book Review: Majmudar PA, Epstein RJ. Excimer Lasers in Ophthalmology. Principles and Practice. Miller N, McGhee C, Taylor H, Gartry D, Trokel S. Am J Ophthalmol 1997.
2. Topical MMC Halts Return of Haze Following RK, PRK. Ophthalmology Times, June 1, 1999, p. 24.
3. Update on Laser Thermal Keratoplasty for Hyperopia, Journal of the Illinois Optometric Association, 57(3), 1999, 7.
4. Raviv T, Epstein RJ, Majmudar PA. Mitomycin-C debridement can treat post-PRK haze. Ophthalmology Times, February 1, 2000, p. 6.
5. Mitomycin-C prevents return of post-PRK haze. Ocular Surgery News, April 15, 2000, p. 31. 6. Raviv T, Majmudar PA, Dennis RF, Epstein RJ. Oxygen assures flap adherence after
LASIK. Ophthalmology Times, June 1, 2000, p. 6.
7. “Mitomycin C Tretament Can Prevent Post-PRK Haze,” Journal of the Illinois Optometric Association, 58(5), 2000, 57-58.
8. Majmudar, PA. “The Ideal Keratome?” Journal of the Illinois Optometric Association, 59(2), Spring 2001, 32.
9. Rao SN, Majmudar PA. LTK may have role in correcting hyperopia after LASIK. Ophthalmology Times, June 1, 2001, p. 8-9.
10. Rao SN, Majmudar PA, Epstein RJ. Topography system can image posterior surface of cornea. Ophthalmology Times, July 1, 2001, p.14-15.
11. Majmudar PA. “LASEK: Looking Ahead or Revisiting the Past” Journal of the Illinois Optometric Association, 59(3), Summer 2001, 30.
12. Majmudar PA . “Experience with Durable Keratomes.” Refractive Eyecare for Ophthalmologists, August 2001, p. 5-7.
13. Majmudar PA. “Using the Orbscan Corneal Topography System,” Journal of the Illinois Optometric Association, 59(4), Fall 2001, p. 30.
14. Majmudar, PA. “Mitomycin C and PRK Haze,” Cataract and Refractive Surgery Today. Oct. 2001
15. Majmudar, PA. Lasek in High Myopia, Eye World Dec 2001
16. Majmudar PA. “Treatment of Late Flap Striae Following LASIK,” Journal of the Illinois Optometric Association, 59(5), Winter 2001, 55.
17. Majmudar PA. “Prophylactic MMC in high-risk PRK,” Cataract and Refractive Surgery Today April 2002.
18. Majmudar, PA. “Surgeons Have Many Choices in Microkeratomes,” Ophthalmology Times. May 1, 2002, 35-40.
19. Majmudar PA. “Point-Counterpoint: Prophylactic MMC in high-risk PRK,” Cataract and Refractive Surgery Today, July 2002.
20. Majmudar PA. “A New Masquerade Syndrome in LASIK,” Journal of the Illinois Optometric Association, 60(3), Summer 2002, 8-9.
21. “New techniques, awareness help limit PRK complications,” Ophthalmology Times. October 1, 2002, p. 1.
22. “Amadeus is simple to use, consistent, surgeon says”. Ocular Surgery News, October 1, 2002, p. 39.
23. Majmudar PA. “Wavefront Technology Gets Closer to Reality in the USA,” Journal of the Illinois Optometric Association, 60(5), Winter 2002, 40.
24. Majmudar, PA. “A New Masquerade Syndrome in Post-LASIK,” Cataract and Refractive Surgery Today. Feb 2003, 28-9.
25. Muller LT, Majmudar PA, Epstein RJ. “Mitomycin-C for post-PRK Haze and Complicated LASIK Flaps,” Review of Refractive Surgery, February 2003, 15-17.
26. Treatment and Prevention of Corneal Haze, Eye World, March 2003.
27. Samalonis L, Majmudar PA, Blade Oscillation Velocity Debated, Eye World, April 2003, p. 57. 28. Majmudar PA. “Lasik Complications,” AAO Focal Points, September 2004.
29. Majmudar, PA. “Post-LASIK Irregular Astigmatism,” Cataract and Refractive Surgery Today. Vol. 4, No.9, Sept. 2004, 33-7.
30. Majmudar, PA. “Personal Experience with Amniotic Membrane Transplantation,” Cataract and Refractive Surgery Today. Jan. 2005, 3.
LETTERS TO THE EDITOR:
1. Majmudar PA: Review of Ophthalmology, 1998
2. Majmudar PA, Dennis RF, Epstein RJ: Treatment of post-PRK Haze. Ocular Surgery News, August 15, 2000, p. 6.
3. Raviv T, Majmudar PA, Epstein RJ: Mitomycin-C for Post-PRK Corneal Haze. J Cataract Refract Surg, 26: August 2000, 1105-6.
4. Majmudar PA , Raviv T, Dennis RF, Epstein RJ: Subepithelial Fibrosis After RK. J Cataract Refract Surg, 26: October 2000, 1433-4.
5. Majmudar PA, Dennis RF, Epstein RJ: Authors’ reply to “Topical MMC for Subepithelial Fibrosis after Refractive Corneal Surgery,” Ophthalmology 108(2), February 2001, 239-40. 6. Rao SN, Majmudar PA, Epstein RJ: Transepithelial PTK.PRK over Complicated LASIK Flaps.
J Refract Surg, 17: Jul/Aug 2001, 470.
7. Epstein RJ, Majmudar PA, Pepper Spray in the Eye. Ophthalmology 2001, 108(10), 1712-3.
PRESENTATIONS AT INTERNATIONAL MEETINGS:
1. Invited Speaker: “Mitomycin C in Refractive Surgery,” Seoul, South Korea, November 9, 2002.
2. Invited Speaker: “Flap Suturing for Recalcitrant Striae and Epithelial Ingrowth Following LASIK,” Korean Society of Cataract and Refractive Surgery, Seoul, South Korea, November 10, 2002.
3. Invited Speaker: Mitomycin-C in Refractive Surgery Course, European Society of Cataract and Refractive Surgery (ESCRS) Annual Meeting, Munich, Germany, September 2003.
4. Invited Speaker: “My Experience with the Amadeus Microkeratome,” AMO Booth, European Society of Cataract and Refractive Surgery (ESCRS), Munich, Germany, September 2003. 5. Invited Speaker: Mitomycin-C in Refractive Surgery Course, European Society of Cataract
and Refractive Surgery (ESCRS) Annual Meeting, Paris, France, September 2004. 6. Invited Speaker: “Haze Prevention Strategies in Surface Ablation,” 63rd All-India
Ophthalmological Society (AIOS) Conference, Bhubaneswar, India, January 14, 2005.
COURSES TAUGHT AT NATIONAL MEETINGS:
1. Invited Instructor - Modern Incisional Refractive Surgery Course, American Academy of Ophthalmology Annual Meeting, San Francisco, 1997
2. Invited Instructor - Modern Incisional Refractive Surgery Lab, American Academy of Ophthalmology Annual Meeting, San Francisco, 1997
3. Invited Faculty - “Making the Transition From A Conventional Ophthalmology Practice to Refractive Surgery” - International Society of Refractive Surgery Meeting, San Francisco, 1997
4. Invited Instructor - Modern Incisional Refractive Surgery Course, American Academy of Ophthalmology Annual Meeting, New Orleans, November 1998.
5. Invited Instructor - Modern Incisional Refractive Surgery Lab, American Academy of Ophthalmology Annual Meeting, New Orleans, November 1998.
6. Invited Instructor – Astigmatism in Cataract Surgery Lab, American Academy of Ophthalmology Annual Meeting, New Orleans, November 1998.
7. Invited Speaker: LASIK/PRK Course Wet Lab, International Society of Refractive Surgery Annual Meeting, Orlando, 1999.
8. Invited Speaker: Refractive Surgery Course, International Society of Refractive Surgery Annual Meeting, “Essential Elements of the Refractive Surgery Patient Seminar,” “Current Status of Holmium LTK for Hyperopia,” Orlando, October 1999.
9. Invited Instructor – Astigmatism in Cataract Surgery Lab, American Academy of Ophthalmology Annual Meeting, Orlando, October 1999.
10. Invited Instructor – Astigmatism in Cataract Surgery Lab, American Academy of Ophthalmology Annual Meeting, Dallas, October 2000.
11. Invited Course Director: “Update on Microkeratomes: Avoidance and Management of
Complications,” Contact Lens Association of Ophthalmologists, Las Vegas, NV; February 14, 2001.
12. Invited Speaker: LASIK/PRK Course Wet Lab, International Society of Refractive Surgery Annual Meeting, New Orleans, 2001.
13. Course Co-Director: Mitomycin-C in Refractive Surgery Course, American Academy of Ophthalmology Annual Meeting, Orlando, October 2002.
14. Invited Instructor: Lasik Course HO-521, American Academy of Ophthalmology Annual Meeting, Orlando, October 2002.
15. Course Director: “The Expanding Role of MMC in Refractive Surgery,” American Society of Cataract and Refractive Surgery, San Francisco, April 13, 2003.
16. Invited Course Faculty: “Surface Ablation Over Previous LASIK Flaps,” American Society of Cataract and Refractive Surgery, San Francisco, April 15, 2003.
17. Course Co-Director: Mitomycin-C in Refractive Surgery Course, American Academy of Ophthalmology Annual Meeting, Anaheim, CA, November 2003.
18. Invited Faculty: The Comprehensive LASIK Course, American Academy of Ophthalmology Annual Meeting, Anaheim, CA, November 2003.
19. Invited Faculty: Cataract and Astigmatism Course, American Academy of Ophthalmology Annual Meeting, Anaheim, CA, November 2003.
20. Course Director: “The Expanding Role of MMC in Refractive Surgery,” American Society of Cataract and Refractive Surgery, San Diego, May, 2004.
21. Invited Faculty: “LASEK Course,” “Haze Prevention Strategies Following LASEK,” American Society of Cataract and Refractive Surgery, San Diego, May, 2004.
22. Invited Faculty: The Comprehensive LASIK Course, American Academy of Ophthalmology Annual Meeting, New Orleans, LA, October 2004.
23. Course Faculty: Mitomycin-C in Refractive Surgery Course, American Academy of Ophthalmology Annual Meeting, New Orleans, LA, October 2004.
24. Invited Faculty: Cataract and Astigmatism Course, American Academy of Ophthalmology Annual Meeting, New Orleans, LA, October 2004.
PRESENTATIONS AT NATIONAL MEETINGS:
1. Majmudar PA, Khadem J, Goins, KM: The Role of Photodynamic Biologic Tissue Adhesive in Corneal Transplantation, Presented as a poster at ARVO, 1995.
2. Majmudar PA, Gabrielian K, Oganesian A, Goins, KM: The Anti-proliferative Effect of Minoxidil on Human Lens Epithelium In Vitro, Presented as a paper at ARVO, 1996.
3. Arun VV, Majmudar PA, Gabrielian K, Goins, KM: The Effect of Minoxidil on Human Lens Epithelial Cell Viability and Morphology In Vitro, Presented as a poster at ARVO, 1997.
4. Majmudar PA, Arun VV, Gabrielian K, Rezai K, Goins, KM: Persistence of Minoxidil-Induced Inhibition of Human Lens Epithelial Proliferation In Vitro, Presented as a poster at ARVO, 1997.
5. Majmudar PA, Brenart R, Epstein RJ: Topical Mitomycin-C For Massive Subepithelial Fibrosis Following Radial Keratotomy. Castroviejo Cornea Society, San Francisco, 1997. 6. Majmudar PA, Epstein RJ, Interface Keratitis Following LASIK, International Society of
Refractive Surgery, San Francisco, 1997.
7. Majmudar PA, Forstot SL, Nirankari VS, Dennis RF, Brenart R, Epstein RJ: Topical
Mitomycin-C for Subepithelial Fibrosis Following Refractive Corneal Surgery and Penetrating Keratoplasty. International Society of Refractive Surgery Annual Meeting, New Orleans, 1998.
8. Majmudar PA, Forstot SL, Nirankari VS, Dennis RF, Brenart R, Epstein RJ: Topical Mitomycin-C for Subepithelial Fibrosis Following Refractive Corneal Surgery. American Academy of Ophthalmology Annual Meeting, Orlando, October 1999.
9. Majmudar PA, Forstot SL, Nirankari VS, Dennis RF, Brenart R, Epstein RJ: Topical Mitomycin-C for Subepithelial Fibrosis Following Refractive Corneal Surgery: Update. American Society of Cataract and Refractive Surgery Annual Meeting, Boston, May 2000. 10. Faculty: “Complex cases with LASIK,” American Society of Cataract and Refractive Surgery
Annual Meeting, Boston, May 2000.
11. Invited Speaker: Lasik Complications, Alabama Academy of Ophthalmology, August 2000. 12. Invited Speaker: Various topics in LASIK, Vision Quest 2000, The Lasik Institute, Chicago,
IL, August 2000.
13. Invited Speaker: Rao SN, Majmudar PA. Discussion of paper, “Lasik Enhancement after PRK.” American Academy of Ophthalmology Annual Meeting, Dallas, October 2000. 14. Invited Speaker: “LASIK panel discussion,” VCA Annual Meeting, Aspen, CO, February 8,
2001
15. Invited Speaker: “Lasik Complications: Video presentation,” Contact Lens Association of Ophthalmologists, Las Vegas, NV; February 14, 2001.
16. Invited Speaker: “Initial Experience with the Amadeus and Moria M2 Microkeratomes,” LaserVision Centers, Inc., Annual Clinical Meeting, San Diego, April 2001.
17. Invited Speaker: “Initial Experience with the Amadeus Microkeratome,” Allergan Booth, American Society of Cataract and Refractive Surgery, San Diego, April 2001.
18. Invited Speaker: Advanced Techniques in Refractive Surgery, “Therapeutic and Prophylactic Uses of Mitomycin C in Refractive Surgery,” American Society of Cataract and Refractive Surgery, San Diego, April 2001.
19. Invited Speaker: Various topics in LASIK, Vision Quest 2001, The Lasik Institute, Chicago, IL, August 2001.
20. Invited Speaker: “PRK Complications,” Refractive Surgery 2001 Subspecialty Day, American Academy of Ophthalmology, New Orleans, LA; November 9, 2001.
21. Invited Speaker/Group Leader: “Refractive Surgery Discussion,” Refractive Surgery 2001 Subspecialty Day, American Academy of Ophthalmology, New Orleans, LA; November 9-10, 2001.
22. Invited Speaker: Majmudar PA, Lane HA. Discussion of paper, “Prophylactic Use of MMC following PRK in high myopia.” American Academy of Ophthalmology Annual Meeting, New Orleans, November 2001.
23. Majmudar PA “Prophylactic Use of Mitomycin C in the Management of Buttonholed LASIK Flaps, International Society of Refractive Surgery Annual Meeting, New Orleans, 2001. 24. Invited Speaker: “Microkeratome Technology,” Ocular Surgery News: Update on
Therapeutics and Ocular Surgery,” Dana Point, CA, February 2002.
25. Lane HA, Majmudar PA, “Flap Reproducibility with the Amadeus Microkeratome,” American Society of Cataract and Refractive Surgery, Philadelphia, June 2002.
26. Spanggord HM, Lane HA, Dennis RF, Majmudar PA, Epstein RJ. “Comparison of Glare and Halo between the Visx S3 with VSS and Technolas 217 Excimer Laser Systems,” American Society of Cataract and Refractive Surgery, Philadelphia, June 2002.
27. Epstein RJ, Majmudar PA, ”Role of Mitomycin-C in Refractive Surgery,” American Society of Cataract and Refractive Surgery, Philadelphia, June 2002.
28. Invited Panelist: “Surface Ablation,” Refractive Surgery 2002 Subspecialty Day, American Academy of Ophthalmology, Orlando, FL; October 18, 2002.
29. Invited Speaker/Group Leader: “Refractive Surgery Discussion,” Refractive Surgery 2002 Subspecialty Day, American Academy of Ophthalmology, Orlando, FL; October 18, 2002. 30. Invited Speaker: “The Future of Wound Healing Modifiers in Refractive Surgery,”
CLES/CLAO Meeting, Orlando, FL, January 2003.
31. Invited Speaker: “LASIK Complications,” CLES/CLAO Meeting, Orlando, FL, January 2003. 32. Muller LT, Candal EM, Dennis RF, Epstein RJ, Majmudar PA, ”Transepithelial PTK/PRK
with Adjunctive MMC for Complicated Lasik Flaps,” American Society of Cataract and Refractive Surgery, San Francisco, April 12, 2003.
33. Invited Judge: Scientifc Poster Competition, American Society of Cataract and Refractive Surgery, San Francisco, April 12, 2003.
34. Invited Session Moderator: “LASIK,” Session 4U, American Society of Cataract and Refractive Surgery, San Francisco, April 15, 2003.
35. Invited Speaker: “My Experience with the Amadeus Microkeratome,” AMO Booth, American Society of Cataract and Refractive Surgery, San Francisco, April 2003.
36. Candal EM, Muller LT, Dennis RF, Epstein RJ, Majmudar PA, ”Prophylactic Mitomycin-C for High-Risk PRK and LASEK,” American Society of Cataract and Refractive Surgery, San Francisco, April 13, 2003.
37. Candal EM, Muller LT, Dennis RF, Epstein RJ, Majmudar PA, ”Comparison of Post-LASIK Glare and Halos with the VISX S3 and the Technolas 217a Excimer Laser Systems,” American Society of Cataract and Refractive Surgery, San Francisco, April 15, 2003. 38. Invited Speaker: “Haze Prevention Strategies after LASEK,” Third International LASEK
Congress, Houston, TX, March 20, 2004.
39. Invited Speaker: “Haze Prevention Strategies After Surface Ablation,” and “Flap Suturing for Recalcitrant Striae and Epithelial Ingrowth Following LASIK,” The Society of Air Force Clinical Surgeons Annual Meeting, San Francisco, CA, April 7, 2004.
40. Invited Judge: Scientifc Poster Competition, American Society of Cataract and Refractive Surgery, San Diego, May 1, 2004.
41. Invited Session Panelist: American Society of Cataract and Refractive Surgery, San Diego, May 4, 2004.
42. Majmudar PA, “Comparison of Wavefront and Patient Outcomes With Silicone and Acrylic IOLs,” American Society of Cataract and Refractive Surgery, San Diego, May 4, 2004. 43. Invited Speaker: “Wavefront and Patient Outcomes With Silicone and Acrylic IOLs,” AMO
Booth, American Society of Cataract and Refractive Surgery, San Diego, May 2004.
44. Candal EM, Majmudar PA, Epstein RJ. “Wavefront Analysis and Keratoconus Screening in Refractive Surgery,” American Society of Cataract and Refractive Surgery, San Diego, May 2, 2004.
45. Invited Speaker: “Managing Challenging Cases in Refractive Surgery,” Bausch & Lomb Booth, American Society of Cataract and Refractive Surgery, San Diego, May 2004. 46. Klein S, Majmudar PA, Epstein RJ. “Time Comparison of MMC Application in High-Risk
PRK,” American Society of Cataract and Refractive Surgery, San Diego, May 3, 2004. 47. Seldomridge D, Majmudar PA, Epstein RJ. “Time Comparison of MMC Application in
High-Risk PRK,” The Cornea Society Annual Meeting, New Orleans, LA, October 2004.
48. Invited Panelist: “Patient Outcomes With Silicone and Acrylic IOLs,” AMO Booth, American Academy of Ophthalmology Annual Meeting, New Orleans, LA, October 2004.
PRESENTATIONS AT REGIONAL/LOCAL MEETINGS:
1. Faculty: United Vision Associates, “Refractive Surgery Update Course,” February 1998. 2. Lecturer: Rotary Club, Arlington Heights, IL, “LASIK and Refractive Surgery,” July 1998. 3. Lecturer: United Vision Associates, “Refractive Surgery Update Course,” September 1998. 4. Course Co-Director, CLAO Regional Contact Lens Symposium, October 1998.
6. Lecturer: Rotary Club, Evanston, IL, “LASIK and Refractive Surgery,” October 1998. 7. Lecturer: Rush Medical College, Department of Medicine Grand Rounds, “Ocular
Manifestations of Systemic Diseases,” January 1999.
8. Lecturer: United Vision Associates, “Refractive Surgery Update Course,” February 1999. 9. Invited Speaker: Highland Park Hospital, Department of Medicine Grand Rounds, “Ocular
Manifestations of Systemic Diseases,” March 1999.
10. Invited Speaker: Rush Medical College, Department of Allergy and Immunology, “Immunologic Diseases Of The Cornea and External Eye,” April 1999.
11. Lecturer: Lions Club of Highwood, IL, “Common Ocular Problems in the Elderly,” “LASIK and Refractive Surgery,” April 1999.
12. Faculty – How to choose a comanaging surgeon, EyeQuest, Rosemont, IL, May 1999 13. Lecturer: St. Alexius Medical Center, Department of Family Medicine Grand Rounds, “Ocular
Manifestations of Systemic Diseases,” May 1999.
14. Lecturer: United Vision Associates, “INTACS,” September 1999.
15. Invited Speaker: Illinois Optometric Association, “Current Status of Holmium LTK for Hyperopia,” October 1999.
16. Invited Speaker: Laser Vision Centers, Inc. Optometric Comanagement Seminar, “LASIK: Techniques, Results and Complications,” “INTACS Comanagement,” October 1999. 17. Invited Speaker: Chicago Medical Society/Midwest Clinical Conference, “Refractive Surgery
Update,” February 2000.
18. Lecturer: United Vision Associates, “INTACS,” September 1999.
19. Invited Speaker: “Refractive Surgery in the New Millennium,“ Lasers in the New Millennium, Midwest Eye Physicians, March 2000
20. Invited Speaker: “Immunology of the Cornea and External Eye, Part I: Type I Hypersensitivity Disorders,” Chicago, IL, Sponsored by Allergan, April 18, 2000.
21. Invited Speaker: “Immunology of the Cornea and External Eye, Part I: Type I Hypersensitivity Disorders,” Chicago, IL, Sponsored by Allergan, April 26, 2000.
22. Invited Speaker: “Immunology of the Cornea and External Eye, Part I: Type I Hypersensitivity Disorders,” Pittsburgh, PA, Sponsored by Allergan, June 15, 2000.
23. Invited Speaker: “Immunology of the Cornea and External Eye, Part I: Type I Hypersensitivity Disorders,” Detroit, MI, Sponsored by Allergan, June 21, 2000.
24. Invited Speaker: “Immunology of the Cornea and External Eye, Part I: Type I Hypersensitivity Disorders,” Grand Rapids, MI, Sponsored by Allergan, June 27, 2000.
25. Invited Speaker: “Immunology of the Cornea and External Eye, Part I: Type I Hypersensitivity Disorders,” Cleveland, OH, Sponsored by Allergan, August 9, 2000.
26. Invited Speaker: “Immunology of the Cornea and External Eye, Part I: Type I Hypersensitivity Disorders,” Muskegon, MI, Sponsored by Allergan, September 6, 2000.
27. Invited Speaker: “Immunology of the Cornea and External Eye, Part I: Type I Hypersensitivity Disorders,” Appleton, WI, Sponsored by Allergan, September 19, 2000.
28. Invited Speaker: “Treatment and Prevention of Corneal Haze with Topical Mitomycin-C,” Illinois Optometric Association, Springfield, IL, September 21, 2000.
29. Invited Speaker: “Current State of Custom Ablations,” Rush Glaucoma and Refractive Surgery Update, Chicago IL, November 18, 2000..
30. Lecturer: United Vision Associates, “Wavefront Technology,” February 2001. 31. Invited Speaker: “Refractive Surgery in the New Millennium,” Illinois Association of
Ophthalmology, March 2001.
32. Invited Panelist: Refractive Surgery Symposium, Illinois Association of Ophthalmology, March 2001.
33. Invited Speaker: “Avoidance and Management of LASIK Complications,” Nebraska Ophthalmology Society, March 2001.
34. Lecturer: United Vision Associates, “LASEK,” September 2001.
35. Invited Speaker: “Immunology of the Cornea and External Eye, Part I: Type I Hypersensitivity Disorders,” Chicago, IL, Sponsored by Allergan, September, 2001.
36. Invited Speaker: “New Directions in Corneal Transplantation,” Illinois Optometric Association, Springfield, IL, October 6, 2001.
37. Invited Speaker: “Immunology of the Cornea and External Eye, Part I: Type I Hypersensitivity Disorders,” Detroit, MI, Sponsored by Allergan, March 15, 2002.
38. Invited Speaker: “Immunology of the Cornea and External Eye, Part I: Type I Hypersensitivity Disorders,” Warren, MI, Sponsored by Allergan, March 16, 2002.
39. Invited Speaker: “Refractive Surgery Update, Ocular Allergy,” Richland County Medical Society, Mansfield, OH, May 17, 2002.
40. Invited Speaker: “Immunology of the Cornea and External Eye, Part I: Type I Hypersensitivity Disorders,” Austin, TX, Sponsored by Allergan, August 8, 2002.
41. Invited Speaker: “Refractive Surgery Update” Midwest Eye Physicians, Palos Heights, IL, August 28, 2002.
42. Invited Speaker: “Advances in Surface Ablation,” Illinois Optometric Association, Springfield, IL, September 2002.
43. “Common Eye Problems: Advances in Patient Care,” Marriott Assisted Living Center, Hoffman Estates, IL, October 8, 2002.
44. Invited Speaker: “Refractive Surgery Update” AIPNO conference, Cleveland, OH, November 2, 2002.
45. Faculty: “Cataracts and Corneal Disease,” “Advances in Refractive Cataract Surgery,” Midwest Eye Physicians Cataract Symposium, February 23, 2003.
46. Invited Speaker: Chicago Medical Society/Midwest Clinical Conference, “Refractive Surgery Update 2003,” March 22, 2003.
47. Invited Speaker: “Immunology of the Cornea and External Eye, Part I: Type I Hypersensitivity Disorders,” Charleston, WV, Sponsored by Allergan, April 1, 2003.
48. Invited Speaker: “Ocular Allergy & Advances in the Treatment of Dry Eye Syndrome,” Peoria, IL, Sponsored by Allergan, April 8, 2003.
49. Invited Speaker: “Advances in the Treatment of Dry Eye Syndrome,” Lafayette, IN, Sponsored by Allergan, April 22, 2003.
50. Invited Speaker: “Advances in the Treatment of Dry Eye Syndrome,” University of Indiana, Department of Ophthalmology Grand Rounds, Indianapolis, IN, April 23, 2003.
51. Invited Speaker: “Advances in the Treatment of Dry Eye Syndrome,” and “Challenges and Progress in Ocular Infection,” Austin, TX, Sponsored by Allergan, May 28, 2003.
52. Invited Speaker: “Advances in the Treatment of Dry Eye Syndrome,” and “Challenges and Progress in Ocular Infection,” El Paso, TX, Sponsored by Allergan, June 10, 2003. 53. Invited Speaker: “Advances in the Treatment of Dry Eye Syndrome,” and “Challenges and
Progress in Ocular Infection,” Appleton, WI, Sponsored by Allergan, July 30, 2003. 54. Invited Speaker: “Advances in the Treatment of Dry Eye Syndrome,” and “Challenges and
Progress in Ocular Infection,” Marquette, MI, Sponsored by Allergan, August 12, 2003. 55. Invited Speaker: “The Future of Refractive Surgery,” Illinois Optometric Association, Itasca, IL,
October 10, 2003.
56. Invited Speaker: “Advances in the Treatment of Dry Eye Syndrome,” and “Challenges and Progress in Ocular Infection,” Salt Lake City, UT, Sponsored by Allergan, November 6, 2003. 57. Invited Speaker: “Lasik Complications,” Midwest Vision Expo, Rosemont, IL May 13, 2004. 58. Invited Faculty: “Haze Prevention Strategies in Surface Ablation,” Illinois Optometric
